120 related articles for article (PubMed ID: 15057015)
1. Angiolymphoid hyperplasia with eosinophilia: successful treatment with the antiallergic agent suplatast tosilate.
Harada K; Kambe Y; Takeda H; Nakano H; Hanada K
Dermatology; 2004; 208(2):176-7. PubMed ID: 15057015
[No Abstract] [Full Text] [Related]
2. Kimura's disease treated with suplatast tosilate and loratadine.
Ueda T; Arai S; Amoh Y; Katsuoka K
Eur J Dermatol; 2011; 21(6):1020-1. PubMed ID: 21914581
[No Abstract] [Full Text] [Related]
3. [A case of eosinophilic cystitis that was treated with oral suplatast tosilate (IPD-1151T)].
Watanabe M; Yamaguchi K; Yamanishi T; Kamai T; Yoshida K
Hinyokika Kiyo; 2009 Nov; 55(11):715-9. PubMed ID: 19946192
[TBL] [Abstract][Full Text] [Related]
4. Angiolymphoid hyperplasia with eosinophilia on the leg successfully treated with T-helper cell 2 cytokine inhibitor suplatast tosilate.
Bito T; Kabashima R; Sugita K; Tokura Y
J Dermatol; 2011 Mar; 38(3):300-2. PubMed ID: 21342240
[No Abstract] [Full Text] [Related]
5. Selective enhancement of production of IgE, IgG4, and Th2-cell cytokine during the rebound phenomenon in atopic dermatitis and prevention by suplatast tosilate.
Kimata H
Ann Allergy Asthma Immunol; 1999 Mar; 82(3):293-5. PubMed ID: 10094221
[TBL] [Abstract][Full Text] [Related]
6. Effect of suplatast tosilate on goblet cell metaplasia in patients with asthma.
Hoshino M; Fujita Y; Saji J; Inoue T; Nakagawa T; Miyazawa T
Allergy; 2005 Nov; 60(11):1394-400. PubMed ID: 16197471
[TBL] [Abstract][Full Text] [Related]
7. Effect of suplatast tosilate, an antiallergic selective Th2 cytokine inhibitor, on acute eosinophilic myocarditis: a case report.
Umemoto S; Itagaki K; Kimura M; Itoh S; Tanaka M; Haraguchi M; Matsuzaki M
Heart Vessels; 2003 May; 18(2):100-2. PubMed ID: 12756607
[TBL] [Abstract][Full Text] [Related]
8. Usefulness of suplatast tosilate, a Th2 cytokine inhibitor based on the Th1/Th2 ratio for allergic disease in children: a retrospective study.
Yoshihara S; Fukuda H; Arisaka O
Arzneimittelforschung; 2011; 61(7):421-4. PubMed ID: 21899211
[TBL] [Abstract][Full Text] [Related]
9. [The effect of suplatast tosilate on immunological parameters for the patients with atopic dermatitis].
Suto H; Mitsuishi K; Hira K; Uchida T; Unno T; Ogawa H; Yoshiike T; Takamori K
Arerugi; 2000 Dec; 49(12):1163-72. PubMed ID: 11197882
[TBL] [Abstract][Full Text] [Related]
10. [A case report of eosinophilic cystitis treated with oral suplatast tosilate].
Kuramoto T; Senzaki H; Inagaki T
Hinyokika Kiyo; 2014 Sep; 60(9):447-50. PubMed ID: 25293800
[TBL] [Abstract][Full Text] [Related]
11. Suplatast tosilate inhibits eosinophil production and recruitment into the skin in murine contact sensitivity.
Satoh T; Sasaki G; Wu MH; Yokozeki H; Katayama I; Nishioka K
Clin Immunol; 2003 Sep; 108(3):257-62. PubMed ID: 14499249
[TBL] [Abstract][Full Text] [Related]
12. Kimura's disease associated with bronchial asthma presenting eosinophilia and hyperimmunoglobulinemia E which were attenuated by suplatast tosilate (IPD-1151T).
Tsukagoshi H; Nagashima M; Horie T; Oyama T; Yoshii A; Sato T; Iizuka K; Dobashi K; Mori M
Intern Med; 1998 Dec; 37(12):1064-7. PubMed ID: 9932643
[TBL] [Abstract][Full Text] [Related]
13. Early intervention with suplatast tosilate for prophylaxis of pediatric atopic asthma: a pilot study.
Yoshihara S; Ono M; Yamada Y; Fukuda H; Abe T; Arisaka O
Pediatr Allergy Immunol; 2009 Aug; 20(5):486-92. PubMed ID: 19210644
[TBL] [Abstract][Full Text] [Related]
14. Anti-inflammatory effect of suplatast tosilate on mild asthma.
Sano Y; Miyamoto T; Makino S
Chest; 1997 Sep; 112(3):862-3. PubMed ID: 9315837
[No Abstract] [Full Text] [Related]
15. Prophylactic effectiveness of suplatast tosilate in children with asthma symptoms in the autumn: a pilot study.
Yoshihara S; Yamada Y; Fukuda H; Tsuchiya T; Ono M; Fukuda N; Kanno N; Arisaka O
Allergol Int; 2014 Jun; 63(2):199-203. PubMed ID: 24561769
[TBL] [Abstract][Full Text] [Related]
16. Kimura's disease presenting as the middle mediastinal mass.
Zhang C; Hu J; Feng Z; Jin T
Ann Thorac Surg; 2009 Jan; 87(1):314-6. PubMed ID: 19101326
[TBL] [Abstract][Full Text] [Related]
17. Suplatast tosilate (IPD), a new immunoregulator, is effective in vitiligo treatment.
Nihei Y; Nishibu A; Kaneko F
J Dermatol; 1998 Apr; 25(4):250-5. PubMed ID: 9609984
[TBL] [Abstract][Full Text] [Related]
18. Suplatast tosilate alters DC1/DC2 balance in peripheral blood in bronchial asthma.
Yokomura K; Suda T; Matsuda H; Hashizume H; Asada K; Suzuki K; Chida K
J Asthma; 2005 Sep; 42(7):567-70. PubMed ID: 16169790
[TBL] [Abstract][Full Text] [Related]
19. High-dose corticosteroids for asthma.
Payne D
Lancet; 2000 Oct; 356(9239):1444. PubMed ID: 11052616
[No Abstract] [Full Text] [Related]
20. Oral suplatast tosilate for the treatment of urticaria pigmentosa, skin lesion in mastocytosis.
Nishihira M; Miura H
Int J Dermatol; 2019 Feb; 58(2):e38-e39. PubMed ID: 30456758
[No Abstract] [Full Text] [Related]
[Next] [New Search]
